MELA Sciences to Provide Corporate Overview at the Craig-Hallum Capital Group's 2014 Alpha Select Conference
09/17/2014
Rose Crane, CEO of MELA Sciences, will provide a corporate overview at the Craig-Hallum Capital Group's 2014 Alpha Select Conference in New York City.
Crane will discuss the latest FDA Pre-Market Approval of the MelaFind® System.
To learn more go to: www.melafind.com